Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00127556 · ClinicalTrials.gov registry record · NA

Transfusion Medicine - Prevention of Bedside Errors

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Completed
Registry status
NA
Development phase
300
Enrollment target

NCT00127556: Completed NA study, sponsored by Dartmouth-Hitchcock Medical Center.

NCT00127556 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00127556, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.

COMPLETED
Registry status
NA
Development phase
300 participants
Enrollment target

Study Summary

This study concerns the safety of blood transfusion. Prior to transfusion, staff should perform a number of essential safety checks to ensure that the correct patient is receiving the correct blood product. Evidence suggests that these safety checks are not always done. This study has been designed to assess the effect of a simple intervention on the performance of the bedside safety check. The hypothesis is that a simple intervention will improve the performance of the bedside check.

Interventions

  • PROCEDURE Label applied to blood bag

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2005-04
Est. Completion 2005-12
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What the finished NCT00127556 record still lists

NCT00127556 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which Label applied to blood bag is the first listed.

NCT00127556 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00127556 about?

NCT00127556 is a clinical study titled "Transfusion Medicine - Prevention of Bedside Errors". This study concerns the safety of blood transfusion. Prior to transfusion, staff should perform a number of essential safety checks to ensure that the correct patient is receiving the correct blood product. Evidence suggests that these safety checks are not always done. This study has been designed ...

What is the current status of trial NCT00127556?

This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2005-04. Estimated completion is 2005-12.

What interventions are being tested in trial NCT00127556?

The interventions under investigation include: Label applied to blood bag (PROCEDURE).

Who is sponsoring clinical trial NCT00127556?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00127556's enrollment target sits among peer trials

300 330th of 2000 higher than 1,630 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00127556, the US trial registry maintained by the National Library of Medicine. NCT00127556 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.